# A Study of ALTY-0501 for the Treatment of Dry Eye Administered 4 Times a Day for a 56 Day Period

> **NCT00439400** · PHASE2 · COMPLETED · sponsor: **Alacrity Biosciences, Inc.** · enrollment: 160 (actual)

## Conditions studied

- Dry Eye

## Interventions

- **DRUG:** doxycycline
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT00439400
- **Lead sponsor:** Alacrity Biosciences, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-02
- **Primary completion:** —
- **Final completion:** 2007-08
- **Target enrollment:** 160 (ACTUAL)
- **Last updated:** 2007-10-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00439400

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00439400, "A Study of ALTY-0501 for the Treatment of Dry Eye Administered 4 Times a Day for a 56 Day Period". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT00439400. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*